相似文献
1
Cryptococcus neoformans Galactoxylomannan contains an epitope(s) that is cross-reactive with Aspergillus Galactomannan.
J Clin Microbiol. 2005 Jun;43(6):2929-31. doi: 10.1128/JCM.43.6.2929-2931.2005.
2
Galactoxylomannan does not exhibit cross-reactivity in the platelia Aspergillus enzyme immunoassay.
Clin Vaccine Immunol. 2007 May;14(5):624-7. doi: 10.1128/CVI.00368-06. Epub 2007 Mar 14.
3
Aspergillus galactomannan enzyme-linked immunosorbent assay cross-reactivity caused by invasive Geotrichum capitatum.
J Clin Microbiol. 2006 Sep;44(9):3432-4. doi: 10.1128/JCM.00856-06.
4
Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.
5
Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neoformans.
Diagn Immunol. 1984;2(2):109-15.
6
An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.
Res Immunol. 1990 Jan;141(1):33-42. doi: 10.1016/0923-2494(90)90099-k.
7
Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.
Eukaryot Cell. 2009 Jan;8(1):96-103. doi: 10.1128/EC.00331-08. Epub 2008 Oct 24.
8
Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.
Vaccine. 2011 Feb 24;29(10):1891-8. doi: 10.1016/j.vaccine.2010.12.134. Epub 2011 Jan 14.
9
Monoclonal Antibody AP3 Binds Galactomannan Antigens Displayed by the Pathogens , and .
Front Cell Infect Microbiol. 2019 Jul 16;9:234. doi: 10.3389/fcimb.2019.00234. eCollection 2019.
10
Bifidobacterium lipoteichoic acid and false ELISA reactivity in aspergillus antigen detection.
Lancet. 2004 Jan 24;363(9405):325-7. doi: 10.1016/S0140-6736(03)15393-7.
引用本文的文献
1
False-Positive Galactomannan Test Results in Multiple Myeloma.
Diseases. 2025 Apr 17;13(4):118. doi: 10.3390/diseases13040118.
2
An inexpensive point-of-care immunochromatographic test for Talaromyces marneffei infection based on the yeast phase specific monoclonal antibody 4D1 and Galanthus nivalis agglutinin.
PLoS Negl Trop Dis. 2021 May 4;15(5):e0009058. doi: 10.1371/journal.pntd.0009058. eCollection 2021 May.
3
A Collaborative Tale of Diagnosing and Treating Chronic Pulmonary Aspergillosis, from the Perspectives of Clinical Microbiologists, Surgical Pathologists, and Infectious Disease Clinicians.
J Fungi (Basel). 2020 Jul 11;6(3):106. doi: 10.3390/jof6030106.
4
Monoclonal Antibody AP3 Binds Galactomannan Antigens Displayed by the Pathogens , and .
Front Cell Infect Microbiol. 2019 Jul 16;9:234. doi: 10.3389/fcimb.2019.00234. eCollection 2019.
5
Clinical features and cause analysis of false positive results of Aspergillus galactomannan assay in pulmonary cryptococcosis patients.
Eur J Clin Microbiol Infect Dis. 2019 Apr;38(4):735-741. doi: 10.1007/s10096-019-03469-3. Epub 2019 Jan 25.
6
Circulating DNA Is Quantitatively Correlated to Galactomannan in Serum.
Front Microbiol. 2017 Oct 31;8:2040. doi: 10.3389/fmicb.2017.02040. eCollection 2017.
7
Galactofuranose antigens, a target for diagnosis of fungal infections in humans.
Future Sci OA. 2017 Jun 1;3(3):FSO199. doi: 10.4155/fsoa-2017-0030. eCollection 2017 Aug.
8
Usefulness of Two Aspergillus PCR Assays and Aspergillus Galactomannan and β-d-Glucan Testing of Bronchoalveolar Lavage Fluid for Diagnosis of Chronic Pulmonary Aspergillosis.
J Clin Microbiol. 2017 Jun;55(6):1738-1746. doi: 10.1128/JCM.02497-16. Epub 2017 Mar 22.
9
Galactomannan Assay and Invasive Pulmonary Aspergillosis - Comparison of the Test Performance at an in-house and the Kit Cut-off.
J Clin Diagn Res. 2016 Aug;10(8):DC01-4. doi: 10.7860/JCDR/2016/19175.8310. Epub 2016 Aug 1.
10
Point of Care Testing for the Diagnosis of Fungal Infections: Are We There Yet?
Curr Fungal Infect Rep. 2016;10:43-50. doi: 10.1007/s12281-016-0254-5. Epub 2016 Apr 7.
本文引用的文献
1
False-positive Aspergillus galactomannan enzyme-linked immunosorbent assay results in vivo during amoxicillin-clavulanic acid treatment.
J Clin Microbiol. 2004 Nov;42(11):5362-3. doi: 10.1128/JCM.42.11.5362-5363.2004.
2
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance.
J Infect Dis. 2004 Aug 1;190(3):641-9. doi: 10.1086/422009. Epub 2004 Jul 1.
3
False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam.
Clin Infect Dis. 2004 Mar 15;38(6):913-6. doi: 10.1086/382224. Epub 2004 Feb 27.
4
A yeast under cover: the capsule of Cryptococcus neoformans.
Eukaryot Cell. 2003 Aug;2(4):655-63. doi: 10.1128/EC.2.4.655-663.2003.
5
Transient aspergillus antigenaemia: think of milk.
Lancet. 2002 Apr 6;359(9313):1251. doi: 10.1016/S0140-6736(02)08238-7.
6
Aspergillus fumigatus and aspergillosis.
Clin Microbiol Rev. 1999 Apr;12(2):310-50. doi: 10.1128/CMR.12.2.310.
7
Structural characterization of the galactoxylomannan of Cryptococcus neoformans Cap67.
Carbohydr Res. 1998 Jan;306(1-2):315-30. doi: 10.1016/s0008-6215(97)10058-1.
8
Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan.
J Clin Microbiol. 1997 Jan;35(1):257-60. doi: 10.1128/jcm.35.1.257-260.1997.
9
New cause for false-positive results with the Pastorex Aspergillus antigen latex agglutination test.
J Clin Microbiol. 1993 Sep;31(9):2489-90. doi: 10.1128/jcm.31.9.2489-2490.1993.
10
Polysaccharide antigens of the capsule of Cryptococcus neoformans.
Infect Immun. 1994 May;62(5):1507-12. doi: 10.1128/iai.62.5.1507-1512.1994.
Zotero 插件